Pfizer Ltd to stop Minipress XL sales, receives $13.9M

Pfizer Ltd announced that it will discontinue the marketing, distribution, and sale of Minipress XL effective September 7, 2026. This decision follows Pfizer Inc. USA's discontinuation of Minipress XL manufacturing. In connection with this, Pfizer Ltd will receive a one-time payment of USD 13.9 Million (approximately Rs. 131.38 Crore) from Pfizer Inc. USA. The board meeting where this outcome was decided commenced at 10:33 a.m. and concluded at 11:03 a.m. on September 7, 2026.